ly 353381 has been researched along with ly 117018 in 1 studies
| Studies (ly 353381) | Trials (ly 353381) | Recent Studies (post-2010) (ly 353381) | Studies (ly 117018) | Trials (ly 117018) | Recent Studies (post-2010) (ly 117018) |
|---|---|---|---|---|---|
| 70 | 12 | 15 | 105 | 0 | 0 |
| Protein | Taxonomy | ly 353381 (IC50) | ly 117018 (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.12 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentrem, D; Dardes, RC; De Los Reyes, A; Jordan, VC; Lee, ES; O'Regan, RM; Schafer, JM | 1 |
1 other study(ies) available for ly 353381 and ly 117018
| Article | Year |
|---|---|
Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts.
Topics: Animals; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Female; Humans; Mice; Mice, Nude; Piperidines; Pyrrolidines; Selective Estrogen Receptor Modulators; Tamoxifen; Thiophenes; Time Factors; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |